Home -
Products -
Antibody Drug Conjugates (ADC) -
ADCs Linker/Click Chemistry -
Hydroxy-PEG4-(CH2)2-Boc
Hydroxy-PEG4-(CH2)2-Boc
CAS No. 518044-32-1
Hydroxy-PEG4-(CH2)2-Boc( —— )
Catalog No. M24491 CAS No. 518044-32-1
Hydroxy-PEG4-(CH2)2-Boc is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG4-(CH2)2-Boc is extracted from patent WO2004008101A2 (compound 191).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 37 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHydroxy-PEG4-(CH2)2-Boc
-
NoteResearch use only, not for human use.
-
Brief DescriptionHydroxy-PEG4-(CH2)2-Boc is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG4-(CH2)2-Boc is extracted from patent WO2004008101A2 (compound 191).
-
DescriptionHydroxy-PEG4-(CH2)2-Boc is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG4-(CH2)2-Boc is extracted from patent WO2004008101A2 (compound 191).
-
In VitroADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
-
In Vivo——
-
Synonyms——
-
PathwayAntibody Drug Conjugates (ADC)
-
TargetADCs Linker/Click Chemistry
-
RecptorNon-cleavable
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number518044-32-1
-
Formula Weight322.39
-
Molecular FormulaC15H30O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OC(C)(C)C)CCOCCOCCOCCOCCO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Qingqi Chen,et al. The use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates. Patent WO2004008101A2.
molnova catalog
related products
-
DOTA-ADIBO
DOTA-ADIBO is a Click Chemistry intermidate used for antibody-drug conjugates.
-
Val-cit-PAB-OH
Val-cit-PAB-OH is a cleavable ADC linker.
-
Boc-Val-Cit-PAB
Boc-Val-Cit-PAB is a cleavable ADC linker. Boc-Val-Cit-PAB used in the synthesis of antibody-drug conjugates (ADCs).?
Cart
sales@molnova.com